Citation: Rw. Buckheit, Non-nucleoside reverse transcriptase inhibitors: perspectives on novel therapeutic compounds and strategies for the treatment of HIV infection, EXPERT OP I, 10(8), 2001, pp. 1423-1442
Authors:
Casimiro-Garcia, A
De Clercq, E
Pannecouque, C
Witvrouw, M
Loftus, TL
Turpin, JA
Buckheit, RW
Fanwick, PE
Cushman, M
Citation: A. Casimiro-garcia et al., Synthesis and anti-HIV activity of cosalane analogues incorporating two dichlorodisalicylmethane pharmacophore fragments, BIO MED CH, 9(11), 2001, pp. 2827-2841
Authors:
Buckheit, RW
Watson, K
Fliakas-Boltz, V
Russell, J
Loftus, TL
Osterling, MC
Turpin, JA
Pallansch, LA
White, EL
Lee, JW
Lee, SH
Oh, JW
Kwon, HS
Chung, SG
Cho, EH
Citation: Rw. Buckheit et al., SJ-3366, a unique and highly potent nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 (HIV-1) that also inhibits HIV-2, ANTIM AG CH, 45(2), 2001, pp. 393-400
Authors:
Xu, GZ
Loftus, TL
Wargo, H
Turpin, JA
Buckheit, RW
Cushman, M
Citation: Gz. Xu et al., Solid-phase synthesis of the alkenyldiarylmethane (ADAM) series of non-nucleoside HIV-1 reverse transcriptase inhibitors, J ORG CHEM, 66(18), 2001, pp. 5958-5964
Authors:
Santhosh, KC
Paul, GC
De Clercq, E
Pannecouque, C
Witvrouw, M
Loftus, TL
Turpin, JA
Buckheit, RW
Cushman, M
Citation: Kc. Santhosh et al., Correlation of anti-HIV activity with anion spacing in a series of cosalane analogues with extended polycarboxylate pharmacophores, J MED CHEM, 44(5), 2001, pp. 703-714
Authors:
Xu, GZ
Micklatcher, M
Silvestri, MA
Hartman, TL
Burrier, J
Osterling, MC
Wargo, H
Turpin, JA
Buckheit, RW
Cushman, M
Citation: Gz. Xu et al., The biological effects of structural variation at the meta position of thearomatic rings and at the end of the alkenyl chain in the alkenyldiarylmethane series of non-nucleoside reverse transcriptase inhibitors, J MED CHEM, 44(24), 2001, pp. 4092-4113
Authors:
Casimiro-Garcia, A
De Clercq, E
Pannecouque, C
Witvrouw, M
Stup, TL
Turpin, JA
Buckheit, RW
Cushman, M
Citation: A. Casimiro-garcia et al., Synthesis and anti-HIV activity of cosalane analogues incorporating nitrogen in the linker chain, BIO MED CH, 8(1), 2000, pp. 191-200
Authors:
Paul, GC
De Clercq, E
Pannecouque, C
Witvrouw, M
Loftus, TL
Turpin, JA
Buckheit, RW
Cushman, M
Citation: Gc. Paul et al., Identification of optimal anion spacing for anti-HIV activity in a series of cosalane tetracarboxylates, BIOORG MED, 10(18), 2000, pp. 2149-2152
Authors:
Buckheit, RW
Russell, JD
Xu, ZQ
Flavin, M
Citation: Rw. Buckheit et al., Anti-HIV-1 activity of calanolides used in combination with other mechanistically diverse inhibitors of HIV-1 replication, ANTIVIR CHE, 11(5), 2000, pp. 321-327
Authors:
Xu, ZQ
Kern, ER
Westbrook, L
Allen, LB
Buckheit, RW
Tseng, CKH
Jenta, T
Flavin, MT
Citation: Zq. Xu et al., Plant-derived and semi-synthetic calanolide compounds with in vitro activity against both human immunodeficiency virus type 1 and human cytomegalovirus, ANTIVIR CHE, 11(1), 2000, pp. 23-29
Authors:
Stoddart, CA
Moreno, ME
Linquist-Stepps, VD
Bare, C
Bogan, MR
Gobbi, A
Buckheit, RW
Bedard, J
Rando, RF
McCune, JM
Citation: Ca. Stoddart et al., Antiviral activity of 2 '-deoxy-3 '-oxa-4 '-thiocytidine (BCH-10652) against lamivudine-resistant human immunodeficiency virus type 1 in SCID-hu Thy/Liv mice, ANTIM AG CH, 44(3), 2000, pp. 783-786
Authors:
Zaharevitz, DW
Gussio, R
Wiegand, A
Jalluri, R
Pattabiraman, N
Kellogg, GE
Pallansch, LA
Yang, SS
Buckheit, RW
Citation: Dw. Zaharevitz et al., Discovery of novel HIV-1 reverse transcriptase inhibitors using a combination of 3D database searching and 3D QSAR, MED CHEM RE, 9(7-8), 1999, pp. 551-564
Authors:
Buckheit, RW
Russell, JD
Pallansch, LA
Driscoll, JS
Citation: Rw. Buckheit et al., Anti-human immunodeficiency virus type 1 (HIV-1) activity of 2 '-fluoro-2 ',3 '-dideoxyarabinosyladenine (F-ddA) used in combination with other mechanistically diverse inhibitors of HIV-1 replication, ANTIVIR CHE, 10(3), 1999, pp. 115-119
Authors:
Buckheit, RW
Lackman-Smith, C
Snow, MJ
Halliday, SM
White, EL
Ross, LJ
Agrawal, VK
Broom, AD
Citation: Rw. Buckheit et al., PMTI, a broadly active unusual single-stranded polyribonucleotide, inhibits human immunodeficiency virus replication by multiple mechanisms, ANTIVIR CHE, 10(1), 1999, pp. 23-32
Authors:
Buckheit, RW
White, EL
Fliakas-Boltz, V
Russell, J
Stup, TL
Kinjerski, TL
Osterling, MC
Weigand, A
Bader, JP
Citation: Rw. Buckheit et al., Unique anti-human immunodeficiency virus activities of the nonnucleoside reverse transcriptase inhibitors calanolide A, costatolide, and dihydrocostatolide, ANTIM AG CH, 43(8), 1999, pp. 1827-1834
Authors:
Ruell, JA
De Clercq, E
Pannecouque, C
Witvrouw, M
Stup, TL
Turpin, JA
Buckheit, RW
Cushman, M
Citation: Ja. Ruell et al., Synthesis and anti-HIV activity of cosalane analogues with substituted benzoic acid rings attached to the pharmacophore through methylene and amide linkers, J ORG CHEM, 64(16), 1999, pp. 5858-5866
Authors:
Casimiro-Garcia, A
Micklatcher, M
Turpin, JA
Stup, TL
Watson, K
Buckheit, RW
Cushman, M
Citation: A. Casimiro-garcia et al., Novel modifications in the alkenyldiarylmethane (ADAM) series of non-nucleoside reverse transcriptase inhibitors, J MED CHEM, 42(23), 1999, pp. 4861-4874
Authors:
Shortnacy-Fowler, AT
Tiwari, KN
Montgomery, JA
Buckheit, RW
Secrist, JA
Seela, FA
Citation: At. Shortnacy-fowler et al., Synthesis and biological activity of 2 '-fluoro-D-arabinofuranosylpyrazolo[3,4-d]pyrimidine nucleosides, HELV CHIM A, 82(12), 1999, pp. 2240-2245
Authors:
Tutonda, MG
Buckheit, RW
Agrawal, VK
Broom, AD
Citation: Mg. Tutonda et al., Antiviral oligo- and polyribonucleotides containing selected triazolo[2,3-a]purines, J MED CHEM, 41(25), 1998, pp. 4958-4964